Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 2/20 | 0.47 |
| ▸ | JAK1 | P23458 | 2/20 | 0.47 |
| ▸ | TYK2 | P29597 | 2/20 | 0.47 |
| ▸ | JAK3 | P52333 | 1/20 | 0.47 |
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | NAMPT | P43490 | 2/20 | 0.42 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.42 |
| ▸ | CDK9 | P50750 | 1/20 | 0.42 |
| ▸ | DTYMK | P23919 | 1/20 | 0.42 |
| ▸ | CCNK | O75909 | 1/20 | 0.41 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.41 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.41 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21714188 | 0.84 | HSD11B1 (0.54) | JAK2JAK1TYK2JAK3GPR119 | |
| SCHEMBL21714627 | 0.80 | CCNT1 (0.55) | JAK1GPR119POLBNAMPTCCNT1 | |
| SCHEMBL21714335 | 0.79 | JAK1 (0.61) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL21714519 | 0.79 | HSD11B1 (0.55) | JAK2JAK1TYK2JAK3CCNK | |
| SCHEMBL21714165 | 0.77 | JAK1 (0.59) | JAK2JAK1TYK2JAK3GPR119 | |
| SCHEMBL18324978 | 0.77 | GRM4 (0.52) | JAK2JAK3POLBCDK9ALDH1A1 | |
| SCHEMBL21714104 | 0.77 | GPR119 (0.48) | JAK2JAK1TYK2JAK3GPR119 | |
| SCHEMBL20111931 | 0.76 | HSD11B1 (0.54) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL29468210 | 0.76 | JAK2 (0.52) | JAK2JAK1TYK2JAK3GPR119 | |
| SCHEMBL14737550 | 0.76 | JAK2 (0.52) | JAK2JAK1TYK2JAK3GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10961238-B2 | Modulators of hedgehog (Hh) signaling pathway | E-THERAPEUTICS PLC (GB) | 2021-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961238-B2 | Modulators of hedgehog (Hh) signaling pathway | SHH, GLI1, SMO | JAK2 143/4885JAK1 119/4885TYK2 3517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.